Core Viewpoint - The company, Yidu Tech (02158), is actively repurchasing shares, signaling confidence in its long-term value while also making significant strides in business collaborations within the healthcare sector [1] Group 1: Share Repurchase - On January 30, Yidu Tech repurchased approximately 786,000 shares at around HKD 5.8 per share, costing over HKD 4.5 million [1] - The total amount spent on share repurchases over the past five days exceeds HKD 9.5 million, indicating a strong commitment to enhancing shareholder value [1] Group 2: Business Collaborations - Yidu Tech has established a strategic partnership with the Nanshan District People's Hospital in Shenzhen, launching the first domestic "AI + Health Management" innovative system that covers "full-time, full-domain, full-population, and full-cycle" [1] - This initiative aims to create a closed-loop AI medical ecosystem from research and development to application and transformation, marking a significant step in the implementation of smart healthcare solutions [1] Group 3: Market Developments - The company has reported that the number of participants in the 2026 "Beijing Universal Health Insurance" program has surpassed 4.5 million, showcasing its operational capabilities [1] - Additionally, Yidu Tech has collaborated with the First Affiliated Hospital of Chongqing Medical University to launch an "AI Assistant for General Medicine," further expanding its influence in the healthcare sector [1] - Market observers note that the combination of continuous share repurchases and multiple business collaborations highlights the company's dual strategy of "technological breakthroughs + scenario implementation," deepening its impact in the fields of medical intelligence and universal health [1]

Core Viewpoint - The company, Yidu Tech (02158), announced a share buyback plan, indicating confidence in its stock value and future prospects [1] Group 1: Buyback Details - The company will repurchase 786,300 shares at a total cost of HKD 4.5579 million [1] - The buyback price per share ranges from HKD 5.72 to HKD 6.00 [1]

Group 1 - The company, Yidu Tech (02158), announced a share buyback plan on January 30, 2026, involving an expenditure of HKD 4.5579 million to repurchase 786,300 shares [1] - The buyback price is set between HKD 5.72 and HKD 6.00 per share [1]

格隆汇1月30日丨医渡科技(02158.HK)公告，1月30日耗资455.8万港元回购78.6万股。 ...

FF305 翌日披露報表 (股份發行人 ── 已發行股份或庫存股份變動、股份購回及/或在場内出售庫存股份) 表格類別： 股票 狀態： 新提交 公司名稱： 醫渡科技有限公司 呈交日期： 2026年1月30日 如上市發行人的已發行股份或庫存股份出現變動而須根據《香港聯合交易所有限公司（「香港聯交所」）證券上市規則》(「《主板上市規則》」)第13.25A條 / 《香港聯合交易所有限公司GEM證券 上市規則》(「《GEM上市規則》」)第17.27A條作出披露，必須填妥第一章節 。 | 第一章節 | | | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | 於香港聯交所上市 | 是 | | | 證券代號 (如上市) | 02158 | 說明 | | | | | | | A. 已發行股份或庫存股份變動 | | | | | | | | | | | 已發行股份（不包括庫存股份）變動 | | | 庫存股份變動 | | | | | 事件 | 已發行股份（不包括庫存股份）數 目 | | 佔有關事件 ...

以下为2025年度新质100创新企业榜： 360集团 爱美客 百川智能 柏垠生物 达梦数据 海光信息 华硼中子 极智嘉科技 佳杰云星 金山办公 君实生物 科曼医疗 莱芒生物 老来健康 凌雄科技 Mirxes觅瑞 墨芯人工智能 欧冶半导体 擎朗智能 週届日日 安恒信息 百度慧播星 北京人形 丹诺医药 海康威视 华为终端 剂泰科技 箭元科技 京北方 康盈半导体 快看漫画 蓝箭航天 理工雷科 蚂蚁集团 壓尔线程 默达生物 普瑞基准 深睿医疗 爱连健康 奧比中光 百利天恒 长生医疗 国泰海通证券 寒武纪 火石创造 加速进化 会蝶集团 京东科技 科大讯飞 快手科技 浪潮海岳HOM 立康生命科技 Medidata 魔法原子 纳安生物 阡视科技 深之蓝 1月30日，由经济观察报社举办的2025年度创新峰会成功举办。此次峰会以 "新质领航 创启未来" 为主题，汇聚多名企业家、学者及行业领袖，围 绕人工智能、数字化转型、机器人、生物医药等热点领域，分享前沿动态与创新实践。 随着全球产业竞争进入 "创新竞速、集群突破" 的新阶段，中国正以 "新质生产力" 突破传统增长路径 —— 人工智能重构产业效率、半导体芯片 打破技术壁垒、空 ...

Core Insights - Shenzhen Nanshan District People's Hospital and Yidu Technology have established a strategic partnership to launch an "AI + Health Management" innovative system, aiming to create a closed-loop AI medical ecosystem covering "full-time, full-domain, full-population, and full-cycle" [1][3] Group 1: Strategic Collaboration - The collaboration aims to leverage Yidu Technology's AI capabilities to build a comprehensive health service system that enhances the medical service model and improves public health outcomes [3][4] - The partnership will focus on constructing an "AI Parallel Hospital" and a "24-hour Digital Research Institute," exploring compliant development of medical data elements [4] Group 2: Digital Transformation in Healthcare - The innovative system will integrate clinical diagnosis and health management, providing intelligent services throughout the entire patient journey, from prevention to rehabilitation [3][5] - Yidu Technology's CEO emphasized the company's commitment to empowering the digital transformation of Shenzhen's healthcare industry through systematic capabilities in medical data governance and AI platform construction [5][6] Group 3: Implementation and Future Prospects - The collaboration is expected to enhance hospital operational efficiency, optimize patient service experiences, and strengthen health management capabilities [6][7] - Shenzhen aims to contribute to the intelligent upgrade of the healthcare industry in the Greater Bay Area by exploring replicable paths and providing a "Shenzhen practice" model for digital transformation [7]

Group 1 - The company, Yidu Tech (02158), announced a share buyback on January 28, repurchasing 121,800 shares at approximately HKD 6 per share, totaling around HKD 730,000. This marks the fourth consecutive trading day of buybacks, with a total of approximately 830,000 shares repurchased and nearly HKD 5 million spent, signaling confidence to the market [1] - The company has achieved significant progress in business expansion and product implementation, with the number of participants in the 2026 "Beijing Universal Health Insurance" exceeding 4.5 million. As the main operating platform for this project for five consecutive years, Yidu Tech demonstrates its operational strength and market recognition [1] - Yidu Tech has made breakthroughs in the application of AI in primary healthcare, with the "General Medicine Diagnosis AI Assistant" developed in collaboration with Chongqing Medical University First Affiliated Hospital being implemented in over 20 grassroots medical institutions in Chongqing since its trial run in May 2025, serving more than 1,000 healthcare professionals [1]

Core Viewpoint - The company, Yidu Tech (02158), is actively engaging in share buybacks to instill market confidence while simultaneously achieving significant progress in business expansion and product implementation [1] Group 1: Share Buyback Activity - On January 28, Yidu Tech announced a share buyback of approximately 121,800 shares at around HKD 6 per share, costing about HKD 730,000 [1] - The company has conducted buybacks for four consecutive trading days, totaling approximately 830,000 shares and nearly HKD 5 million in expenditure [1] Group 2: Business Expansion - The number of participants in the 2026 "Beijing Universal Health Insurance" program, which Yidu Tech operates, has surpassed 4.5 million [1] - Yidu Tech has been the main operating platform for this project for five consecutive years, demonstrating its operational strength and market recognition [1] Group 3: Technological Advancements - Yidu Tech has made breakthroughs in the application of AI in healthcare, specifically with the "General Medicine Diagnosis AI Assistant" developed in collaboration with Chongqing Medical University [1] - Since its trial run in May 2025, the AI assistant has been implemented in over 20 grassroots medical institutions in Chongqing, serving more than 1,000 healthcare professionals [1]

医渡科技(02158)公布，2026年1月29日耗资约72.82万港元回购12.18万股股份。 ...